section name header

Indications ⬇

REMS


Unlabeled Use:

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Interactions ⬆ ⬇

Drug-drug:

Drug-Natural Products:

Availability ⬆ ⬇

(Generic available)

Route/Dosage ⬆ ⬇

Renal Allograft Rejection Prevention

Rheumatoid Arthritis

Inflammatory Bowel Disease (Crohn Disease or Ulcerative Colitis) (unlabeled use)

US Brand Names ⬆ ⬇

Azasan, Imuran

Action ⬆ ⬇

  • Antagonizes purine metabolism with subsequent inhibition of DNA and RNA synthesis.
Therapeutic effects:
  • Suppression of cell-mediated immunity and altered antibody formation.

Classifications ⬆ ⬇

Therapeutic Classification: Immunosuppressant agents

Pharmacologic Classification: purine antagonists

Pharmacokinetics ⬆ ⬇

Absorption: Readily absorbed after oral administration. IV administration results in complete bioavailability.

Distribution: Unknown

Metabolism/Excretion: Metabolized to 6-mercaptopurine, which is further metabolized (one route is by thiopurine methyltransferase [TPMT] to form an inactive metabolite; nucleotide diphosphatase [NUDT15] is also involved in inactivation process). Minimal renal excretion of unchanged drug.

Half-Life: 3 hr.

Time/Action Profile ⬆ ⬇

ROUTEONSETPEAKDURATION
PO (anti-inflammatory)6–8 wk12 wkunknown

Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆ ⬇

ay-za-THYE-oh-preen

Code ⬆

NDC Code